[1] |
郑徽, 崔富强, 龚晓红, 等. 我国育龄期妇女乙型肝炎病毒表面抗原及e抗原流行现状分析[J]. 中国疫苗和免疫,2010,16(6):496-499.
|
[2] |
Zhang Z, Chen C, Li Z, et al. Individualized management of pregnant women with high hepatitis B virus DNA levels[J]. World J Gastroenterol,2014,20(34):12056-12061.
|
[3] |
李振华, 解宝江, 张艳丽, 等. 高病毒载量HBV感染妇女孕晚期应用替比夫定抗病毒治疗疗效及安全性[J/CD]. 中华实验和临床感染病杂志(电子版),2012,6(6):558-561.
|
[4] |
吴全新. 替比夫定阻断HBV母婴传播的效果观察及其对HBsAg, HBeAg及抗-HBc胎盘透过率的影响[D] . 重庆: 第三军医大学,2013:1-45.
|
[5] |
庄辉. 预防乙型肝炎病毒母婴传播中值得注意的几个问题[J]. 中华肝脏病杂志,2016,24(12):881-884.
|
[6] |
王贵强, 王福生, 成军, 等. 慢性乙型肝炎防治指南(2015年版) [J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(5):570-589.
|
[7] |
Han GR, Jiang HX, Yue X, et al. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Viral Hepat,2015,22(9):754-762.
|
[8] |
Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus[J]. J Hepatol,2014,61(3):502-507.
|
[9] |
Brown RS Jr, McMahon BJ, Lok AS, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis[J]. Hepatology,2016,63(1):319-333.
|
[10] |
刘苗苗, 贾胜男, 张倩, 等. 妊娠期肝病的临床研究进展[J]. 临床肝胆病杂志,2016,32(2):386-389.
|
[11] |
柳雅立, 田亚坤, 孙文锦, 等. HBV感染自然史研究进展[J]. 中国病原生物学杂志,2009,4(5):374-377.
|
[12] |
Zhang H, Pan CQ, Pang Q, et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice[J]. Hepatology,2014,60(2):468-476.
|
[13] |
Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus[J]. Hepatology,2015,62(2):375-386.
|
[14] |
Sun W, AUID- Oho, Zhao S, et al. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission[J]. BMC Gastroenterol,2017,17(1):51-54.
|
[15] |
庄辉. 预防乙型肝炎病毒母婴传播中值得注意的几个问题[J]. 中华肝脏病杂志,2016,24(12):881-884.
|
[16] |
Tan Z, Yin Y, Zhou J, et al. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy[J]. Medicine (Baltimore), 2016,95(40):484-457.
|
[17] |
Yoo ER, Perumpail RB, Cholankeril G, et al. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers[J]. BMJ Case Rep,2016,12(2):234-257.
|
[18] |
万谟彬. 重视核苷(酸)类似物的妊娠安全性[J/CD]. 中华实验和临床感染病杂志(电子版),2008,2(3):127-130.
|
[19] |
王崇, 曹梦琢, 王川, 等. 妊娠期应用替比夫定降低HBV母婴传播风险的研究进展[J]. 临床肝胆病杂志,2017,33(4):746-750.
|
[20] |
Hu YH, Liu M, Yi W, et al. Tenofovir rescue therapy in pregnant females with chronic hepatitis B[J]. World J Gastroenterol,2015,21(8):2504-2509.
|
[21] |
魏宏, 庞秋梅. 妊娠期抗病毒治疗阻断HBV母婴传播研究进展[J]. 传染病信息,2016,33(2):73-76.
|
[22] |
韩国荣, 丁祎. 慢性乙型肝炎育龄妇女及孕妇的抗病毒治疗指征与时机的选择[J]. 中华肝脏病杂志,2015,23(11):806-809.
|
[23] |
陈新月, 张世斌, 鲁俊峰. 重视慢性乙型肝炎病毒感染者妊娠相关的抗病毒治疗问题[J]. 中华肝脏病杂志,2015,23(11):803-805.
|
[24] |
Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J]. N Engl J Med,2016,374(24):2324-2334.
|
[25] |
Jourdain G, AUID- Oho, Ngo-Giang-Huong N, et al. Prevention of mother-to-child transmission of hepatitis B virus: a phase Ⅲ, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen[J]. BMC Infect Dis,2016,16(8):393-399.
|